首页> 外国专利> USE OF ECM1 GENE-KNOCKOUT MOUSE IN SCREENING OF ANTI-HEPATIC FIBROSIS DRUG

USE OF ECM1 GENE-KNOCKOUT MOUSE IN SCREENING OF ANTI-HEPATIC FIBROSIS DRUG

机译:ECM1基因敲除小鼠在抗肝纤维化药物筛选中的应用

摘要

Provided is the use of an ECM1 gene-knockout mouse in the screening of an anti-hepatic fibrosis drug. Specifically, provided is a method for preparing an animal model of hepatic fibrosis or related diseases thereof in non-human mammals, which method comprises the following steps: (a) providing a non-human mammalian cell and inactivating an ECM1 gene in the cell, thereby obtaining a non-human mammalian cell in which the ECM1 gene is inactivated; and (b) using the cell in which the ECM1 gene is inactivated obtained in step (a) to prepare an animal model of hepatic fibrosis or related diseases thereof in which the ECM1 gene is inactivated. The animal model is an effective animal model of hepatic fibrosis or related diseases thereof, may be used for studying hepatic fibrosis or related diseases thereof, and may be used in the screening and testing of a particular drug.
机译:本发明提供了ECM1基因敲除小鼠在筛选抗肝纤维化药物中的用途。具体地说,提供了一种在非人类哺乳动物中制备肝纤维化或其相关疾病的动物模型的方法,该方法包括以下步骤:(a)提供非人类哺乳动物细胞并使细胞中的ECM1基因失活,从而获得其中ECM1基因失活的非人类哺乳动物细胞;以及(b)使用在步骤(a)中获得的ECM1基因失活的细胞来制备ECM1基因失活的肝纤维化或其相关疾病的动物模型。该动物模型是肝纤维化或其相关疾病的有效动物模型,可用于研究肝纤维化或其相关疾病,并可用于特定药物的筛选和试验。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号